This inventor holds 4 USPTO granted patents. Top assignees: Sociedad Espanola De Especialidades Farmaco-Terapeuticas S.a., Sociedad Espanola De Especialidades Farmacotera Peuticas, Sociedad Espanola De Especialidades Terepeuticas, S.a.. Active years: 1984-1992.
Company Filing History:
1 out of 3 
1 out of 1 
1 out of 1 Years Active: 1984-1992
Title: The Innovative Contributions of Xavier D Cirera
Introduction
Xavier D Cirera is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of vasodilatory agents. With a total of 4 patents to his name, Cirera's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents, Cirera has developed compounds such as the vasodilatory dihydrodibenzocycloheptyliden-ethylpiperazine derivatives. These derivatives are characterized by a specific formula where R represents a substituent selected from a group that includes --CH.dbd.CH.sub.2, --CO.sub.2 C.sub.2 H.sub.5, and --CH.dbd.CH--CO.sub.2 CH.sub.3. Another significant patent involves a dihydrodibenzocycloheptyliden-ethyl-piperazine derivative, which is useful in pharmaceutical compositions for treating conditions responsive to vasodilatory agents.
Career Highlights
Cirera has worked with prominent companies in the pharmaceutical sector, including Sociedad Española de Especialidades Terapéuticas and Sociedad Española de Especialidades Farmacoterapéuticas. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Throughout his career, Cirera has collaborated with notable professionals such as Romeo R Andreoli and Pedro P Lloveras. These collaborations have likely enriched his research and development efforts.
Conclusion
Xavier D Cirera's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical treatments. His work continues to pave the way for new therapeutic options in the healthcare industry.